MedTrace Logo

Neurofeedback for Upper-limb Recovery After Stroke

NCT03766113 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-12-12

No results posted yet for this study

Summary

Interventional study with minimal risks and constraints, prospective, monocentric.

Conditions

Interventions

OTHER

Neurofeedback coupling electroencephalogram and functional MRI in time actual

One visit : Neurofeedback coupling electroencephalogram and functional MRI in time actual

OTHER

Electroencephalogram-neurofeedback program or Neurofeedback-free mental imaging program with electroencephalogram recording

Interventional group (Electroencephalogram-neurofeedback program) : 24 minutes, 3 times a week for 12 weeks in addition to the traditional rehabilitation program. Controle Group (Neurofeedback-free mental imaging) : 24 minutes, 3 times a week for 12 weeks in addition to the traditional rehabilitation program of reference.

OTHER

Neurofeedback coupling electroencephalogram and functional MRI in time actual or a neurofeedback-free mental imaging program with electroencephalogram recording

Interventional group (5 weeks) : 5 sessions of neurofeedback coupling electroencephalogram and functional MRI in time actual and 9 sessions of electroencephalogram-neurofeedback program Controle Group (5 weeks) : 14 sessions of neurofeedback-free mental imaging program

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Simon Butet · Rennes University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2022-07-28
Completion
2022-07-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03766113 on ClinicalTrials.gov